Company intelligence / Profile preview
Bound Therapeutics
Philadelphia, Pennsylvania, United Statesboundtherapeutics.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Bound Therapeutics is a preclinical-stage biotechnology company developing RNA-based therapeutics using its Magic Bullet Designer AI platform to design targeted RNA–peptide nanocomplexes that block pathogenic RNAs such as miR-21 and c-Myc in aggressive cancers including triple negative breast cancer and lung cancer.[1][3][5][6]
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Antisense oligonucleotideSynthetic oligonucleotideRNA therapymRNA-based drugsSmall interfering RNANanoparticle
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Bound Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bound Therapeutics.